In the Boardroom
Refine Search
Biotechnology
UK-based biotech company Oxford BioTherapeutics, focusing on antibody-drug conjugates in the treatment of cancer, has announced the appointment of Eugen Leo as head of clinical development. 11 July 2014
article
Biochemist and cancer pharmacologist Paul Workman has joined Copenhagen-based pharmaceutical company Nuevolution as scientific advisor. 9 July 2014
Pharmaceutical
Danish allergy specialist ALK-Abello has appointed Helle Skov as new Executive Vice President (Product Supply) and member of the Board of Management of ALK-Abelló A/S. 1 July 2014
article
Specialist medical translation agency Conversis Medical has announced the appointment of Mark Hooper as Global Director with immediate effect. 26 June 2014
Biotechnology
Biotechnology firm Retrogenix has announces the appointment of Matthew Britz as North American Business Development Director with immediate effect. 23 June 2014
Generics
The chairman of Israel-based Teva Pharmaceutical Industries, the world’s largest generic drugs company, has indicated that he will step down from his position by year-end. 18 June 2014
Pharmaceutical
UK drug discovery firm Summit, which is focused on therapies for Duchenne muscular dystrophy and Clostridium difficile infection, has established US operations in Cambridge, Massachusetts. 17 June 2014
Pharmaceutical
Up to 2022, Danish diabetes care giant Novo Nordisk expects to hire 6,000 new employees in Denmark, half of whom will work within research and development. The new jobs will have the derived effect of boosting employment by more than 15,000 jobs nationally. 11 June 2014
Biotechnology
US biotech firm Dendreon revealed last evening that John Johnson plans to step down as president and chief executive officer for personal reasons. 10 June 2014
Pharmaceutical
Dieter Weinand will become President of the HealthCare division of German pharma major Bayer Pharmaceuticals, effective August 1, 2014 and at the same time join the Executive Committee of Bayer HealthCare. 5 June 2014
Pharmaceutical
Australia/USA-based Spinifex Pharmaceuticals, a pain drug development company, has announced the appointment of Ronald Marcus as Chief Medical Officer. 5 June 2014
Pharmaceutical
There were a couple of surprise planned departures and relocations revealed at European pharmaceutical majors, first at Germany’s Bayer and also at France’s Sanofi. 4 June 2014
Pharmaceutical
Israel-based Teva Pharmaceutical Industries has announced changes in its senior leadership team. 3 June 2014
Biotechnology
UK-based monoclonal antibody biopharmaceutical company Kymab has announced the appointment of Steve Arkinstall as Chief Scientific Officer and Nigel Clark as Vice President and Head of Business Development. 3 June 2014
Pharmaceutical
Swiss pharma major Novartis has announced the appointment of Bruno Strigini as president of Novartis Oncology, effective June 1, replacing Herve Hoppenot, who quit the post early this year to become chief executive of USA-based Incyte Corp. 1 June 2014
Biotechnology
UK-based drug discovery and development company Summit has announced the appointment of Leopoldo Zambeletti as a Non-Executive Director. 30 May 2014
Pharmaceutical
US pharma giant Pfizer has announced that Morris Birnbaum has joined the company as Chief Scientific Officer for Cardiovascular and Metabolic Disease Research. Dr Birnbaum will report directly to Rod MacKenzie, Group Senior Vice President and Head of PharmaTherapeutics Research & Development. 30 May 2014
Biotechnology
French drugmaker Domain Therapeutics has announced the nomination of Youssef Bennani to the board of directors. 28 May 2014
Biotechnology
Swedish Orphan Biovitrum has announced the appointment of Kirsti Gjellan as Senior Vice President Manufacturing Operations. 27 May 2014
Biotechnology
US biotech company Celgene Corp (Nasdaq: CELG) has announced organizational changes to its leadership team, effective August 1, 2014. 23 May 2014
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze